… cetuximab is able to inhibit growth of epidermal growth factor receptor (EGFR)-expressing
tumour cells in vitro. Moreover, treatment with cetuximab … linked to cetuximab biological effects …

… cetuximab-like” antibodies in vivo using the mimotope approach. Methods: We used the phage
display technique to identify four peptides structurally mimicking the cetuximab … cetuximab …

… To conclude, physicochemical and biological characterization of cetuximab exposed to …
do not influence physicochemical and biological properties of cetuximab. The mild stress …

Cetuximab (CTX) is a chimeric monoclonal antibody (mAb) able to selectively bind to the
epidermal growth factor receptor (EGFR), resulting in inhibition of EGF linkage and …

… Moreover, numerous clinical trials demonstrated cetuximab … data on biological properties
of cetuximab focusing on the … clinical data on biological properties of cetuximab focusing on …

… trials comparing cetuximab with other biological agents will help to establish definitively
the role of cetuximab in the management of SCCHN and mCRC. In the meantime, cetuximab, …

… out a potential loss of activity of the cetuximab contained in the aggregates since the
biological effects observed might only be due to the soluble fraction of cetuximab in the solution. …

… Although anti-cetuximab antibodies were identified in some patients, they were found not to
interfere with the biological properties of cetuximab, such as its ability to bind EGFR (ie, they …

… According to the SmPCs, cetuximab is stable for 48 h at 25 C after dilution and the opened
… of cetuximab and panitumumab in terms of maintenance of their physiochemical, biological, …

… unmodified cetuximab or cetuximab-CHX-A-DTPA conjugate were added to the wells in
triplicate, one set of wells received BSA/PBS without any competitor, along with 125I-cetuximab (…